CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Sales	$ 84,540	$ 178,402
Cost of goods sold	36,079	75,240
Gross profit	48,461	103,162
Operating expenses:
Selling, general and administrative expenses	1,549,572	1,503,206
Research and development costs	17,308	42,249
Total operating expenses	1,566,880	1,545,455
Loss from operations	(1,518,419)	(1,442,293)
Other income (expense)
Cost of repricing warrants to induce exercise	(70,491)
Loss on settlement		(1,500)
Interest income	51	406
Interest expense	(216,828)	(19,159)
Total other income (expense)	(287,268)	(20,253)
Net loss	$ (1,805,687)	$ (1,462,546)
Net loss per common share - basic and diluted	$ (0.07)	$ (0.07)
Weighted average shares outstanding - basic and diluted	25,896,566	22,128,048